1) Thinprep cytologic test(TCT) technique
新柏氏液基细胞学技术
2) Bai-fluid-base thin-preparation cytologic test
新柏氏液基薄层细胞学制片技术
1.
Objective:To explore the practical value of Bai-fluid-base thin-preparation cytologic test(TCT) in gynecologic general survey.
目的:探讨新柏氏液基薄层细胞学制片技术(TCT)在妇科普查中的价值。
3) Thin Prep cytological test
新柏氏薄层液基细胞学技术
4) thinprep cytology test
新柏氏液基薄层细胞学
1.
Methods5403 women were screened with cervical lesions by a Thinprep liquie-based technology such as TCT(Thinprep cytology Test),Positive cases were diagnosed as the lesions degree above or equal to the atypical squamous cells(≥ASC),the incidence status was compared among different age groups which divided by 15 years.
[方法]利用新柏氏液基薄层细胞学技术筛查子宫颈癌5403例,诊断结果大于或等于不典型鳞状细胞(≥ASC)的为阳性病例,并按15岁的间隔进行年龄分组比较。
5) Thin-prep Cytolosy test
新柏氏膜式液基薄层细胞学
1.
Methods HR-HPV was determined with hybrid capture Ⅱ(HC2) approved by America FDA in 526 cases of patients with ASC-US diagnosed by Thin-prep Cytolosy test (TCT).
方法对516例应用新柏氏膜式液基薄层细胞学(TCT)检查为ASC-US患者,采用美国FDA批准的杂交捕获技术(HC2)进行HR-HPV检测。
6) liquid-based cytologic test
超柏氏薄层液基细胞学
补充资料：免疫学技术乙型肝炎早期抗体的测定(见免疫学技术)
中国医学科学院病毒研究所提供
[图]
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条